Digital business breakeven by Q4 FY26
Apollo 24/7 is on track to achieve breakeven by end of FY26, with losses narrowing to ₹73 crore in Q1 from ₹116 crore last year.
APOLLOHOSP / guidance tracker
Keep management guidance in view.
Apollo Hospitals Enterprise · forward-looking guidance across the available source record.
Research layer active
Guidance tracker
What management said would happen.
margins
Hospital margin expansion to 25%+
Healthcare services margins are expected to improve from 24.5% to 25% or higher, before a marginal 100 bps dip from new hospital losses.
700 new beds operational in FY26
Four new hospitals (women's oncology in Delhi, multispeciality in Pune, acquired hospital in Bangalore, multispeciality in Kolkata) will add 700 beds in FY26.
Healthco + Keimed combined revenue of ₹25,000 crore by FY27
The merged entity (Apollo Healthco + Keimed) is expected to achieve a revenue run rate of ₹25,000 crore with 7% EBITDA margin by end of FY27.
Hospital Revenue Growth: 20% for FY27
Management confirmed being on track to deliver 20% revenue growth in the hospitals segment, up from the previously guided mid-teens. Kodaikanal will contribute revenue from Q3-Q4 FY27 onward.
Digital Business Break-even by Q3 FY27
The digital vertical (Apollo HealthCo) is expected to achieve break-even by end of Q3 FY27. Four insurance call centers operational with two already CM2 positive; the fourth engine (pet/retail) is being reworked.
New Hospital Cluster Break-even by Q4 FY28
The cluster of new hospitals is expected to break even by Q3-Q4 of FY28, with Financial District Hyderabad breaking even next quarter and Bellis starting operations this quarter.
Established Hospitals: 13-14% Growth + New Units Adding 7%
Established hospitals will grow at 13-14% while new hospital contributions will add approximately 7% to overall hospital revenue over the next 24 months, sustaining the 20% blended growth trajectory.
Healthcare services organic growth to return to 13%
Management expects healthcare services revenue growth to revert to 13% as Bangladesh patients return and new markets are explored.
New hospital EBITDA losses of ~₹150 crore in FY27
Pre-opening EBITDA losses from six new hospitals are expected to be around ₹150 crore, with break-even targeted within 12 months.
Apollo 24/7 break-even by Q4 FY26
The digital platform is on course to achieve break-even by end of this fiscal year, though insurance investments may cause a slight delay.
HealthCo margin target of 7% by Q4 FY27
Apollo HealthCo aims for a revenue run rate of ₹25,000 crore and 7% EBITDA margin by Q4 FY27, with current H1 margin at 4.4%.
New bed addition of ~1,500 over FY27-28
Approximately 750 beds to be operationalized in FY27 across Hyderabad, Kolkata, Bangalore, and Gurugram, with the balance in early FY28.
Start-up losses of ~₹150 crore in FY27
Management expects total pre-opening and ramp-up losses of around ₹150 crore for new hospitals in the next fiscal year.
Digital business cash break-even by Q1 FY27
Cash EBITDA break-even for Apollo 24/7 delayed by one quarter due to insurance revenue recognition mismatch; otherwise on track.
Existing hospital margin expansion of ~100bps in FY27
Management expects to improve existing hospital EBITDA margins by about 100 basis points through asset utilization and cost initiatives.